Why the study?
Does the transradial approach reduce bleeding complications compared to the transfemoral approach in STEMI patients undergoing primary PCI with abciximab?
Population
1,086 STEMI patients transferred for primary PCI and treated with abciximab, from the EUROTRANSFER registry…
Comparison
Transradial approach for primary PCI vs Transfemoral approach for primary PCI
Design
Cohort
Key result
In STEMI patients treated with primary PCI and abciximab, transradial access was associated with fewer puncture site hematomas than transfemoral access (1.2% vs 9.4%, P<0.001).
Authors
Loading...
May support radial access in STEMI PCI; leaves open practice change without randomized confirmation.
Observational (n=1,086)
Yes
Does the transradial approach reduce bleeding complications compared to the transfemoral approach in STEMI patients undergoing primary PCI with abciximab?
Odds Ratio: 3.54
Absolute Event Rate: 1.2% vs 9.4%
p-value: p=<0.001
In STEMI patients undergoing primary PCI with abciximab, the transradial approach significantly reduces local bleeding complications compared to the transfemoral approach.
Siudak et al. (2010) conducted an observational in ST-elevation myocardial infarction (STEMI) (n=1,086). Transradial approach vs. Transfemoral approach was evaluated on Puncture site hematomas (OR 3.54, p=<0.001). In STEMI patients treated with primary PCI and abciximab, transradial access was associated with fewer puncture site hematomas than transfemoral access (1.2% vs 9.4%, P<0.001).